Results 211 to 220 of about 154,358 (318)

Inositol 1,4,5-Trisphosphate Receptor 1 Gain-of-Function Increases the Risk for Cardiac Arrhythmias in Mice and Humans. [PDF]

Circulation
Sun B, Ni M, Li Y, Song Z, Wang H, Zhu HL, Wei J, Belke D, Cai S, Guo W, Yao J, Tian S, Estillore JP, Wang R, Søndergaard MT, Brohus M, Rohde PD, Mu Y, Vallmitjana A, Benitez R, Hove-Madsen L, Overgaard MT, Fishman GI, Chen J, Sanatani S, Wilde AAM, Fill M, Ramos-Franco J, Nyegaard M, Chen SRW.   +29 more
europepmc   +1 more source

Clinical evaluation and outcome in heart failure patients receiving chemotherapy with different anti‐cancer agents

ESC Heart Failure, EarlyView.
Abstract Background The optimal strategy for modern chemotherapy should be based on a comprehensive approach for cancer patients with cardiovascular diseases. Therefore, cardio‐oncology has received increasing attention owing to the cardiotoxic effects of anti‐cancer therapies.
Tomiko Sunaga, Takahiro Okada, Yoshitaka Iso, Mio Ebato, Tsutomu Toshida, Shuichi Nawata, Hiroshi Suzuki, Mari Kogo   +7 more
wiley   +1 more source

The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias [PDF]

, 1972
John Allen, J M Ekue, R. G. Shanks, S A Zaidi   +3 more
openalex   +1 more source

Estrogen via GPER downregulated HIF-1a and MIF expression, attenuated cardiac arrhythmias, and myocardial inflammation during hypobaric hypoxia. [PDF]

Mol Med
Wowui PI, Mprah R, Ndzie Noah ML, Adu-Amankwaah J, Kanoseh AWL, Tao L, Chulu D, Yalley SK, Shaheen S, Sun H.   +9 more
europepmc   +1 more source

Postoperative Cardiac Arrhythmias in Pediatric and Neonatal Patients with Congenital Heart Disease-A Narrative Review. [PDF]

Life (Basel), 2023
Ganea G, Cinteză EE, Filip C, Iancu MA, Balta MD, Vătășescu R, Vasile CM, Cîrstoveanu C, Bălgrădean M.   +8 more
europepmc   +1 more source

State of precision medicine for heart failure with preserved ejection fraction in a new therapeutic age

ESC Heart Failure, EarlyView.
Abstract Heart failure with preserved ejection fraction (HFpEF) is defined by heart failure (HF) with a left ventricular ejection fraction (LVEF) of at least 50%. HFpEF has a complex and heterogeneous pathophysiology with multiple co‐morbidities contributing to its presentation. Establishing the diagnosis of HFpEF can be challenging.
Roy Rasalam, Andrew Sindone, Gary Deed, Ralph G. Audehm, John J. Atherton   +4 more
wiley   +1 more source

Arrhythmias and Cardiac Output

AJN, American Journal of Nursing, 1972
Patricia Buchholz Kaelin, Gloria Gilbert Mayer   +1 more
openaire   +4 more sources

Cardiac arrhythmias in viral infections. [PDF]

J Interv Card Electrophysiol, 2023
Lee PY, Garan H, Wan EY, Scully BE, Biviano A, Yarmohammadi H.   +5 more
europepmc   +1 more source

Treatment patterns, outcomes and healthcare resource utilization of obstructive hypertrophic cardiomyopathy in England

ESC Heart Failure, EarlyView.
Abstract Aims Describe patient characteristics, treatment patterns, clinical outcomes, healthcare resource utilization (HCRU) and medical costs associated with patients who were diagnosed with obstructive hypertrophic cardiomyopathy (HCM) in clinical practice in England.
Faizel Osman, Carla L. Zema, Michael Hurst, Belinda Sandler, Florence Brellier, Ovie Utuama, Oksana Kirichek, John Houghton, Teresa Lemmer, Maite Tome Esteban   +9 more
wiley   +1 more source

ABILITY OF GLUCAGON TO PRODUCE CARDIAC STIMULATION WITHOUT ARRHYTHMIAS IN HALOTHANE-ANAESTHETIZED ANIMALS

, 1969
Ronald L. Katz, Llynda Hinds, C J Mills
openalex   +1 more source